TELL A FRIEND ABOUT OSMOPREP Mail a Friend

Send a friend a link to this page.

Your Name:
Your E-mail:
Friend's Name:
Friend's E-mail:

Send me a copy of this e-mail
Send me updates about OsmoPrep

ARE YOU AT RISK FOR COLON CANCER?

TAKE THE RISK ASSESSMENT NOW

Print this page:

Font Size:

Find a physician in your area

This national directory of physicians was created so that patients could easily find qualified doctors, such as gastroenterologists and colorectal surgeons, in their area. All physicians in the directory have shown that they are comfortable using OsmoPrep - the Tablet Prep.

Search for a physician in your area

Search within:

of ZIP code:

Search by state:

It is important to note that all physicians in this directory have listed their practice (i) on their own volition, and (ii) have not received any remuneration from Salix. They are also highly experienced in performing screening colonoscopies and treating any type of gastrointestinal health issues and/or conditions.

Should you choose one of the physicians listed, any and all decisions about your care will be made by the physician based upon his or her medical professional opinion. We suggest that you consult with your payer prior to visiting any of the GI physicians listed as you may need a referral.

The use of Physician Finder by any entity or individual to verify the credentials of physicians is prohibited. The database of physician information which drives Physician Finder does not contain sufficient information with which to verify physician credentials under the standards of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO), National Committee for Quality Assurance (NCQA) of the Utilization Review Accreditation Committee (URAC).

Important Safety Information about OsmoPrep

WARNINGS

There have been rare, but serious reports of acute phosphate nephropathy in patients who received oral sodium phosphate products for colon cleansing prior to colonoscopy. Some cases have resulted in permanent impairment of renal function and some patients required long–term dialysis. While some cases have occurred in patients without identifiable risk factors, patients at increased risk of acute phosphate nephropathy may include those with increased age, hypovolemia, increased bowel transit time (such as bowel obstruction), active colitis, or baseline kidney disease, and those using medicines that affect renal perfusion or function (such as diuretics, angiotensin converting enzyme [ACE] inhibitors, angiotensin receptor blockers [ARBs], and possibly nonsteroidal anti–inflammatory drugs [NSAIDs]).

It is important to use the dose and dosing regimen as recommended (PM/AM split dose).

Please see full Prescribing Information for OsmoPrep, including BOXED WARNING.

OsmoPrep^® (sodium phosphate monobasic monohydrate, USP, and sodium phosphate dibasic anhydrous, USP) Tablets are indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. Considerable caution should be advised before OsmoPrep is used in patients with severe renal insufficiency, congestive heart failure, ascites, unstable angina, gastric retention, ileus, severe chronic constipation, bowel perforation, toxic megacolon, gastric bypass or stapling surgery, or hypomotility syndrome. Use with caution in patients with impaired renal function, patients with a history of seizures or at higher risk of seizure, patients with higher risk of cardiac arrhythmias, known or suspected electrolyte disturbances (such as dehydration), or people taking drugs that affect electrolyte levels. Patients with electrolyte abnormalities such as hypernatremia, hyperphosphatemia, hypokalemia, or hypocalcemia should have their electrolytes corrected before treatment with OsmoPrep.

OsmoPrep is contraindicated in patients with a known allergy or hypersensitivity to sodium phosphate salts or any of its ingredients, and in patients with biopsy–proven acute phosphate nephropathy. In clinical trials, the most commonly reported adverse reactions (reporting frequency >3%) were abdominal bloating, nausea, abdominal pain, and vomiting. It is recommended that patients receiving OsmoPrep be advised to adequately hydrate before, during, and after the use of OsmoPrep.